Jane Street Group, LLC Cti Biopharma Corp Transaction History

Jane Street Group, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$4.2 - $6.01 $1.05 Million - $1.5 Million	249,835 Added 312.54%	329,771 $1.39 Million
Q4 2022 Feb 14, 2023	SELL	$4.45 - $6.17 $1.35 Million - $1.87 Million	-302,750 Reduced 79.11%	79,936 $480,000
Q3 2022 Nov 14, 2022	BUY	$5.36 - $7.43 $1.05 Million - $1.45 Million	195,283 Added 104.2%	382,686 $2.23 Million
Q3 2022 Nov 14, 2022	BUY	$5.36 - $7.43 $1.05 Million - $1.45 Million	195,283 Added 104.2%	382,686 $2.23 Million
Q2 2022 Aug 16, 2022	SELL	$3.55 - $6.27 $62,764 - $110,853	-17,680 Reduced 8.62%	187,403 $1.12 Million
Q1 2022 May 17, 2022	BUY	$1.9 - $5.23 $353,654 - $973,480	186,134 Added 982.29%	205,083 $957,000
Q4 2021 Feb 15, 2022	BUY	$1.44 - $2.86 $2,347 - $4,661	1,630 Added 9.41%	18,949 $47,000
Q3 2021 Nov 16, 2021	BUY	$2.25 - $3.18 $38,967 - $55,074	17,319 New	17,319 $51,000
Q4 2020 Feb 17, 2021	SELL	$2.48 - $3.8 $38,487 - $58,972	-15,519 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$1.02 - $2.15 $15,829 - $33,365	15,519 New	15,519 $33,000
Q3 2019 Nov 14, 2019	SELL	$0.64 - $0.92 $88,531 - $127,263	-138,330 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$0.8 - $1.03 $110,664 - $142,479	138,330 New	138,330 $119,000
Q1 2019 May 16, 2019	SELL	$0.9 - $1.37 $11,333 - $17,252	-12,593 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$0.73 - $2.19 $9,192 - $27,578	12,593 New	12,593 $9,000
Q1 2018 May 15, 2018	SELL	$2.7 - $4.06 $475,661 - $715,254	-176,171 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$2.47 - $3.34 $435,142 - $588,411	176,171	176,171 $472,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.